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e.2012.09Abstract Introduction: Most patients with HF due to systolic dysfunction have a signiﬁcant
abnormality on ECG. It is a widely available tool relatively inexpensive, simple to perform, and
yields an instant result.
Aim: To determine whether heart failure (ECG) conveys prognostic and diagnostic information in
patients with HF.
Methods: The study was carried out on 100 heart failure patients. All patients were subjected to
history taking, clinical examination, standard 12 lead ECG (at admission, discharge, and 3 month
follow up) for assessment of the following: (QRS voltage amplitude: in limb leads and in chest leads,
total QRS voltage and transthoracic echocardiography were done for all patients (at discharge and
at 3 month follow up (FU).
Results: There were 75 males and 25 females, aged between 21 and 86 years (mean = 59.14 ± 13.41 -
years). Total QRS voltage, limb leads voltage and chest leads voltage; all signiﬁcantly increased from
admission values (98.54 ± 20.64, 37.87 ± 11.06, and 60.67 ± 15.26 mm) to (110.72 ± 21.28,
43.01 ± 11.92, and 67.71 ± 15.22) at discharge (p< 0.001 for all). Also there was a signiﬁcant
increase in voltage at FU (111.72 ± 21.28, 43.30 ± 11.96, and 68.61 ± 16.61 mm) (p< 0.001 for
all). There was a negative correlation found between left ventricular end diastolic and systolic dimen-
sions (LVEDD and LVESD) with total QRS voltage, chest leads voltage and limb leads voltage, both
at discharge and at FU. The total QRS Voltage was signiﬁcantly higher in patients having no lower
limb (LL) edema than those with edema on admission, at discharge and on FU (p< 0.001).
Conclusion: Voltages of ECG are considered one of the most important parameters in diagnosis and
FU of patients with heart failure. Voltage of chest leads well correlated with LVEDD and LVESD.
Voltage of limb leads has important inverse correlation with LL edema.
ª 2012 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
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146 M. Sadaka et al.1. Introduction
Heart failure (HF) is a common, costly, disabling, and poten-
tially deadly condition. In developed countries, around 2% of
adults suffer from HF, but in those over the age of 65, this in-
creases to 6–10%.1
Patients with advancedHF represent almost 10%of the total
HF population, have the highest short-termmortality, and con-
sume the greatest percentage of resources. The direct costs are
mainly attributed to hospitalizations (approximately 75%).2,3
The diagnosis of HF is dependent on a careful assessment of
the symptoms and signs complemented by diagnostic testing,
for example, chest X-ray, Electrocardiogram (ECG), Echocar-
diography, coronary angiography, and laboratory tests.4
ECG is a widely available tool that has a prognostic value
in HF. It is relatively inexpensive, simple to perform, and
yields an instant result. The measurement is objective and does
not require specialized training to interpret.5,6
Most patients with HF due to systolic dysfunction have a
signiﬁcant abnormality on ECG. A normal ECG makes sys-
tolic dysfunction unlikely and is rare in patients with suspected
HF and has an important role in guiding therapy.6
Low ECG voltage is a marker of the severity of HF and is a
risk factor for adverse outcomes in patients with systolic HF at
1 year.7
The mechanism of the attenuation associated with periphe-
ral edema (PERED) appears to be extracardiac in nature, and
due to a short-circuiting effect on the electrical voltage gener-
ated at the epicardial surface, exerted by the passive volume
conductor containing the heart; the short-circuiting effect in
turn is due to the ﬂuid-based reduction of the electrical imped-
ance of the volume conductor (low resistivity of the excess
ﬂuid).8–11Figure 1 Case example: ECGs A (at admission) and B (at follow
10 mm= 1 mV. Measurements of peak-to-peak amplitudes of the QRS
leads and all 12 ECG leads were manually calculated.Another hypothesis propose that QRS Voltage attenuation
in patients with decompensated HF refer to a combination of
heart-based inﬂuences, and the impact of the PERED, with
different proportions of these two inﬂuences in different pa-
tients depending on the extent of changes in the heart (pres-
sure, volume, and ischemia changes) and the passive body
volume conductor (PERED)10 (see Fig. 1).
This attenuation correlates well with weight gain from ﬂuid
overload, and this association can be put to work in the diag-
nosis and follow-up of such patients. Perusal of serial ECGs of
patients with CHF and PERED indicates that the amplitude of
QRS complexes are at its lowest when the patients show the
highest weight and the most conspicuous PERED on physical
examination. In contrast, the amplitude of QRS complexes is
at its highest when the patients’ weight is at its lowest, and
the PERED has responded favorably to diuresis. This return
to normalcy or improvement is also reproducibly experienced
after hemodialysis12,13 and may be seen in patients with HF
and PERED who have end-stage renal failure and undergo this
procedure.14
The attenuation of ECG voltage/PERED concept can be
utilized in clinical practice and research, and can be employed
either via a quantitative treatment of the 12-lead ECG, or by
‘‘eye-balling’’ the amplitude of leads I and II, at the patient’s
bedside, in the clinic or the ofﬁce, summing the estimates of
amplitude from these 2 leads and comparing serially such val-
ues with gain or loss of patient’s weight or clinical evidence of
PERED.14
ECG is relatively inexpensive, simple to perform and yields
an instant result. The measurement is objective and does not
require specialized training to interpret. The aim of this study
was to determine whether heart failure (ECG) conveys prog-
nostic and diagnostic information in patients with HF.up). ECG was recorded at a speed of 25 mm/s. calibration of
complexes were obtained. Sums of the 6 limb leads. Six precordial
Electrocardiogram as prognostic and diagnostic parameter in follow up of patients with heart failure 1472. Methods
2.1. Study population
The study was carried out on 100 patients hospitalized in the
department of cardiology, Alexandria Main University Hospi-
tal either with acute heart failure (AHF) or decompensated
chronic heart failure (CHF), with the following Inclusion crite-
ria: patient with AHF or decompensated CHF due to either
ischemic heart disease or idiopathic dilated cardiomyopathy
while the exclusion criteria were; patients with aortic stenosis
and/or mitral stenosis, left ventricular outﬂow tract obstruc-
tion and atrial ﬁbrillation (AF).
All patients were subjected to: thorough history taking,
clinical examination and standard 12 lead ECG (at admission,
discharge, and 3 month follow up) for assessment of the fol-
lowing:(QRS voltage amplitude: in limb leads and in chest
leads, total QRS voltage was measured by summing the max-
imum deﬂection of the QRS complex above and below the
base line.15 Transthoracic Echocardiography was done for all
patients (at discharge and at 3 months follow up) for evalua-
tion of the following: wall motion abnormalities, systolic func-
tion: (fractional shortening and ejection fraction also, to
measure ventricular dimensions).16 All patients were followed
up to 3 months as regards NYHA functional classiﬁcation,
rehospitalization, and death.
2.2. Statistical analysis
All clinical, ECG and echocardiographic data of all the pa-
tients were regularly recorded on standard forms and stored.
Statistical analyses were performed with Microsoft Excel and
SPSS software. Data were summarized using means and stan-
dard deviation (SD) for continuous variables, and frequency
for categorical variables. Univariate analysis was performed
either by student’s t-test or Chi-square test, as appropriate.
All p-values were signiﬁcant if 60.05
3. Results
The study included 100 patients, they were 75 males and 25 fe-
males, aged between 21 and 86 years (mean = 59.14 ± 13.41 -
years). Nine patients (9%) had AHF, while (91%) had
previously diagnosed CHF, with a mean duration of
3.48 ± 2.72 years (range = 3 months–11 years). The etiology
of HF in all patients was either ischemic heart disease (IHD)
in 50% of the cases, dilated cardiomyopathy (DCM) in 26%,
hypertension (HTN) in 18%, or valvular heart disease
(VHD) in 6%. Decompensation occurred due to acute
coronary syndrome in 47%, chest infection in 14%, non-
compliance to therapy in 11%, uncontrolled hypertension in
10%, arrhythmias in 9%, anemia in 5%, intake of negative
inotropic drugs in 3%, or thyrotoxicosis in 1%. Seventy per-
cent of the patients were hypertensive, 57% were diabetics,
and 50% had dyslipidemia. Forty-four percent of the patients
were smokers, 17% ex-smokers and 39% were non-smokers.
Patients were hospitalized and evaluated both clinically and
by ECG. Treatment for each patient was individualized
according to his condition. Before discharge and after a fol-
low-up period of 3 months, all patients were subjected toECG and echocardiogram. During the follow-up period, 34
patients were re-hospitalized, from which one case died at
home.
On admission, 4 patients were in NYHA class II, 57 in class
III, and 39 in class IV. Clinical improvement was encountered
at discharge, where 32 patients were in NYHA class I, 56 in
class II, and 12 in class III. At 3 months FU 37 patients were
in NYHA class I, 44 in class II, 14 in class III, and 4 in class
IV. According to Killip classiﬁcation, 17 patients were in Killip
class I, 70 in class II, 11 in class III and 2 in class IV.
3.1. Echocardiographic ﬁnding
The left ventricular end diastolic dimension (LVEDD), end
systolic dimension (LVESD) and the ejection fraction (EF%)
at discharge and on follow-up in all patients and the equivalent
measurements for both groups {non rehospitalized group
(NRG), rehospitalized group (RG)} are shown in Table 1.
There was a signiﬁcant increase in LVEDD and LVESD
with an insigniﬁcant increase in the EF when studying all pa-
tients. However in the NRG, there was no signiﬁcant differ-
ence in the LVEDD and LVESD compared at discharge and
at follow-up (p= 0.06, 0.051, respectively), but there is signif-
icant difference in EF compared at discharge and at follow-up
(p= 0.03). As regards the RG, there was a signiﬁcant increase
in both LVEDD and LVESD and a signiﬁcant decrease in
EF% (p< 0.001 for all).
3.2. ECG ﬁndings (Table 2)
QRS voltage was measured by summing the maximum deﬂec-
tion of the QRS complex above and below the base line.16 The
mathematical summations of voltages in all limb leads and in
all chest leads were calculated, as well as the summation of
both values (Total QRS voltage). These parameters were cal-
culated on admission, at discharge as well as at follow-up.
When studying all patients, the three parameters (Total
QRS voltage, limb leads voltage and chest leads voltage) all
signiﬁcantly increased from admission values (98.54 ± 20.64,
37.87 ± 11.06, and 60.67 ± 15.26 mm) to (110.72 ± 21.28,
43.01 ± 11.92, and 67.71 ± 15.22) at discharge (p< 0.001
for all). Also there was a signiﬁcant increase in voltage at fol-
low-up (111.72 ± 21.28, 43.30 ± 11.96, and 68.61 ± 16.61
mm) (p< 0.001 for all).
Almost similar results were obtained when studying the 66
patients who required no re-hospitalization (NRG). The three
parameters (Total QRS voltage, limb leads voltage and chest
leads voltage) all signiﬁcantly increased from admission values
(105.58 ± 18.29, 39.29 ± 10.95 and 66.29 ± 13.16 mm) to
(117.44 ± 19.66, 44.38 ± 11.89, and 73.06 ± 13.47 mm) at
discharge (p< 0.001 for all) also there was a signiﬁcant in-
crease in voltage at follow-up (120.50 ± 19.99, 45.61 ±
11.70, and 75.15 ± 13.83 mm) (p< 0.001 for all).
Different results were obtained when studying the 34 pa-
tients who required further hospitalization (RG). The three
parameters (Total QRS voltage, limb leads voltage and chest
leads voltage) all signiﬁcantly increased from admission values
(84.88 ± 18.09, 35.12 ± 10.92 and 49.76 ± 13.10 mm) to
(97.68 ± 18.20, 40.35 ± 11.70, and 57.32 ± 13.02 mm) at dis-
charge (p< 0.001 for all), but there was a signiﬁcant decrease
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148 M. Sadaka et al.in voltage at follow-up (94.15 ± 18.49, 38.70 ± 11.27, and
55.45 ± 13.74) (p< 0.001, 0.002, <0.001), respectively.
3.3. Correlation between ECG voltage and Echo data
When studying all patients, a negative correlation was found
between LVEDD and LVESD with the total QRS voltage,
chest leads voltage and limb leads voltage, both at discharge
and at follow-up. A similar ﬁnding (but positive correlation)
was found with the EF% as shown in Table 3.
3.4. Lower limb edema (Table 4)
The Total QRS Voltage was signiﬁcantly higher in patients
having no lower limb (LL) edema than those with edema
on admission, at discharge and on follow-up (p< 0.001). A
similar signiﬁcant ﬁnding existed when studying the Limb
Leads Voltage (p< 0.001), but not with the Chest Leads
Voltage when the difference was insigniﬁcant (p always
>0.4). These results were found in all patients and also in
NRG. In RG, a signiﬁcant correlation was only found with
limb leads voltage.
4. Discussion
Electrocardiogram is a widely available tool that has a prog-
nostic value in HF. It is relatively inexpensive, simple to per-
form, and yields an instant result. The measurement is
objective and does not require specialized training to
interpret.4,5
In our study, as regards the echocardiographic data, the
left ventricular dimensions (both LVEDD and LVESD) were
signiﬁcantly higher among RG at discharge, with a signiﬁ-
cantly lower ejection fraction. At follow up, the latter showed
a signiﬁcant increase in LVEDD and LVESD with signiﬁcant
decline in ejection fraction (p< 0.001). In NRG, there were
no signiﬁcant changes in neither LVEDD nor LVESD be-
tween discharge and follow up, despite a signiﬁcant increase
in ejection fraction (p< 0.03).
In concordance with our study, Vasan et al.17 revealed a
low EF predict outcome in patients with CHF, they evalu-
ated the echocardiograms of 73 patients with CHF (33 wo-
men, 40 men, and mean age 73 years) and 146 age- and
gender-matched control subjects. Impaired LV systolic func-
tion was deﬁned as an LV ejection fraction (LVEF) <0.50.
Thirty-seven CHF cases (51%) had a normal LVEF; 36
(49%) had a reduced LVEF. Women predominated in the
former group (65%), whereas men constituted 75% of the
latter group. During a median follow-up of 6.2 years,
CHF cases with normal LVEF experienced an annual mor-
tality of 8.7% versus 3.0% for matched control subjects.
Congestive heart failure cases with reduced LVEF had an
annual mortality of 18.9% versus 4.1% for matched
control.
In our study, the ECG was studied, especially the QRS
voltage. The QRS voltage was measured in all leads, and cal-
culated the Chest Leads voltage (total voltage in the 6 chest
leads), the Limb Leads voltage (total voltage in the 6 limb
leads), and the Total voltage (mathematical summation of
voltage in the 12 leads).
Table 2 Comparison between limb leads voltage, chest leads voltage, and total QRS voltage at admission, discharge, and follow up.
All patients (n100) Limb leads voltage Chest leads voltage Total QRS voltage
Admission Discharge 3 months Admission Discharge 3 months Admission Discharge 3 months
Range 14– 71 16– 84 16–81 26–94 35–102 34–109 45–156 52–169 54–172
Mean ± SD 37.87 ± 11.06 43.01 ± 11.92 43.30 ± 11.96 60.67 ± 15.26 67.71 ± 15.22 68.61 ± 16.61 98.54 ± 20.64 110.72 ± 21.28 111.72 ± 21.28
p1 Wp< 0.001* Wp< 0.001* p< 0.001* p< 0.001* Wp< 0.001* Wp< 0.001*
p2 Wp= 0.429 p= 0.022* Wp= 0.065
NRG (n= 66) Limb leads voltage Chest leads voltage Total QRS voltage
Admission Discharge 3 months Admission Discharge 3 months Admission Discharge 3 months
Range 19–71 27–84 26–81 37–94 40–102 43–109 65–156 76–169 79–172
Mean ± SD 39.29 ± 10.95 44.38 ± 11.89 45.61 ± 11.70 66.29 ± 13.16 73.06 ± 13.47 75.15 ± 13.83 105.58 ± 18.29 117.44 ± 19.66 120.50 ± 19.99
p1 Wp< 0.001* Wp< 0.001* p< 0.001* p< 0.001* <0.001* <0.001*
p2 Wp< 0.001* p< 0.001* <0.001*
RG (=34) Limb leads voltage Chest leads voltage Total QRS voltage
Admission Discharge 3 Months Admission Discharge 3 Months Admission Discharge 3 Months
Range 14–61 16–66 16–61 26–80 35–88 34–85 45–132 52–145 54–135
Mean ± SD 35.12 ± 10.92 40.35 ± 11.70 38.70 ± 11.27 49.76 ± 13.10 57.32 ± 13.02 55.45 ± 13.74 84.88 ± 18.09 97.68 ± 18.20 94.15 ± 18.4
p1 Wp< 0.001* Wp< 0.001* p< 0.001* p< 0.001* <0.001* <0.001*
p2 Wp< 0.001* p 0.002* <0.001*
p: p value for Paired t-test.
Wp: p value for Wilcoxon signed ranks test.
p1: p value between admission and each other periods.
p2: p value between discharge and 3 months.
* Statistically signiﬁcant at p 6 0.05.
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150 M. Sadaka et al.In the NRG, there was a signiﬁcant increase in voltage from
the admission level to that at discharge, and this remained to
increase at follow-up. This applied to the total QRS voltage;
limb leads voltage, and also chest leads voltage.
On the other hand, in RG, though there was a signiﬁcant
increase in voltage for the three voltage parameters from
admission to discharge, there was a signiﬁcant decline at fol-
low-up. However, the voltage at follow-up was still signiﬁ-
cantly higher than the admission levels. This applied to all
three parameters.
When studying all patients, a signiﬁcant increase in voltage
was noted between the admission and discharge ECG, which
was maintained at follow-up. This applied to the three voltage
parameters studied. However, when comparing the change in
voltage from the value at discharge with its equivalent at fol-
low-up, the only signiﬁcant increase was that obtained from
the summation of voltage in all chest leads, while the change
in total voltage and limb leads voltages was insigniﬁcant. This
could be explained by the opposed changes in NRG and RG.
Russell et al.18 measured and summed the QRS voltage in
all 12 leads of the ECG (
P
QRS) in two cohorts. The ﬁrst in-
cluded 415 patients with low left ventricular ejection fraction,
who were followed-up in a HF clinic. The second cohort
included 100 patients with advanced HF who had an ECG
within 1 year preceding cardiac transplantation. They deﬁned
Low voltage as the lowest quartile of the clinic cohort
(
P
QRS< 12 mV), and its prevalence was compared in the
two cohorts. The associations of low voltage with 1-year out-
comes were assessed in the clinic cohort.
In the clinic cohort, they found that the frequency of low
voltage was higher in patients with NYHA class IV versus those
with class I–III (34% versus 22% respectively, p= 0.04). The
frequency of low voltage in the pre-transplant cohort (47%)
was twice that of the clinic cohort (24%, p< 0.001). After
1 year of follow-up in the clinic cohort, low ECG voltage was
associated with a higher rate of death (14% versus 5%,
p= 0.008), and also with the composite end point of death
or HF hospitalization (35% versus 20%, p= 0.004).
Russell et al.18 concluded that the low ECG voltage is a
marker of the severity of HF, and is a risk factor for adverse
outcomes in patients with systolic HF at 1 year.
In our study, the total QRS voltage and the limb leads volt-
age were correlated and signiﬁcantly higher in patients having
no lower limb edema than those with edema on admission, at
discharge and on follow-up. Such difference was insigniﬁcantTable 3 Correlation between voltage in limb leads, voltage in chest
whole sample (n= 100).
Voltage in Limb leadsa
Discharge 3 months
LVEDD R 0.147 0.202
P 0.061 0.056
LVESD R 0.187 0.178
P 0.062 0.068
EF% R 0.219* 0.256*
P 0.028 0.010
r: Pearson coefﬁcient.
* Statistically signiﬁcant at p 6 0.05.
a Logarithmic normalization of limb leads was used.when studying the chest leads voltage. These ﬁndings were
found in all patients as well as the NRG. In RG, signiﬁcant
correlation was only found with limb leads voltage. A signiﬁ-
cant negative correlation existed between lower limb edema
and voltage in limb leads, whereas it was insigniﬁcant as re-
gards chest leads voltage.
In agreement with our results, Lumlertgul et al.19 studied 20
patients with CHF by recording the ECG and weight on
admission and at discharge. The amplitude of the QRS com-
plexes in all ECG leads was measured and sums of leads I
and II, the six chest leads, the six limb leads, and all 12 leads
were calculated. There was a good correlation between the
weight loss and the increase in the sums of the amplitudes of
the QRS complexes from leads I and II, and the six limb leads,
but a poor correlation with the V1–V6 leads and all 12 leads.
They concluded that the sums of the amplitudes of the QRS
complexes from leads I and II constitute a reliable, easily
obtainable, ubiquitously available, bedside clinical index,
which can be employed in the diagnosis, monitoring of man-
agement, and follow-up of patients with CHF.
Negative signiﬁcant correlation was found between
LVEDD and LVESD with both voltages in chest leads and to-
tal QRS voltage, while this correlation was not signiﬁcant as
regards voltage in limb leads, these results included the whole
patients as well as both the groups.
Talbot et al.20 studied 59 cases, 41 men and 18 women. Left
ventricular volumes were measured by single plane ventricu-
lography and coronary arteriography. The relation of the left
ventricular end-diastolic volumes to the QRS voltage of the
12-lead electrocardiograms was examined.
Talbot et al.20 found that QRS voltage was inversely corre-
lated with volume for group 1 and for group 2; both correla-
tions were the same (r= 0–68). There was no signiﬁcant
correlation for the group of patients with left ventricular
hypertrophy. This could be ascribed to the opposite effect of
hypertrophy on QRS voltage.
In our study the total QRS voltage was signiﬁcantly lower in
patients with lower limb edema than those without lower limb
edema on admission, at discharge, and on follow-up
(p< 0.001). A similar signiﬁcant ﬁnding existed when studying
the limb leads voltage (p< 0.001), but not with the chest leads
voltage when the difference was insigniﬁcant (p always >0.4).
These results were found in all patients and also in NRG. In
RG, signiﬁcant correlation was only found with limb leads
voltage.leads and total QRS voltage with LVEDD, LVESD and EF% in
Voltage in Chest leads Total QRS voltage
Discharge 3 months Discharge 3 months
0.582* 0.607* 0.536* 0.539*
<0.001 <0.001 <0.001 <0.001
0.524* 0.619* 0.488* 0.555*
<0.001 <0.001 <0.001 <0.001
0.491* 0.619* 0.458* 0.563*
<0.001 <0.001 <0.001 <0.001
Table 4 Relation between LL edema with limb leads voltage, chest leads voltage, and total QRS voltage at each different period in the
whole sample (n= 100).
LL edema Test of signiﬁcance
No Yes
Limb leads at admission
Range 33.0–71.0 14.0–45.0 MWp< 0.001*
Mean ± SD 46.97 ± 9.78 32.05 ± 7.28
Limb leads at discharge
Range 38.0–84.0 16.0–54.0 MWp< 0.001*
Mean ± SD 52.08 ± 11.32 37.21 ± 8.12
Limb leads at 3 months
Range 39.0–81.0 16.0–54.0 MWp< 0.001*
Mean ± SD 52.33 ± 10.65 37.43 ± 8.69
Chest leads at admission
Range 30.0–90.0 26.0–94.0 p= 0.567
Mean ± SD 61.77 ± 15.99 59.97 ± 14.87
Chest leads at discharge
Range 37.0–102.0 35.0–101.0 p= 0.599
Mean ± SD 72.72 ± 16.06 67.07 ± 14.76
Chest leads at 3 months
Range 34.0–106.0 34.0–109.0 p= 0.488
Mean ± SD 70.05 ± 17.05 67.67 ± 16.39
Total QRS voltage at admission
Range 75.0–156.0 45.0–129.0 p< 0.001*
Mean ± SD 108.74 ± 20.18 92.02 ± 18.27
Total QRS voltage at discharge
Range 87.0–169.0 52.0–140.0 p< 0.001*
Mean ± SD 120.79 ± 21.16 104.28 ± 18.85
Total QRS voltage at 3 months
Range 86.0–172.0 54.0–149.0 p< 0.001*
Mean ± SD 121.90 ± 22.71 105.10 ± 20.96
p: p value for Mann Whitney test.
p: p value for Student’s t-test.
* Statistically signiﬁcant at p 6 0.05.
Electrocardiogram as prognostic and diagnostic parameter in follow up of patients with heart failure 151Madias et al.21 concluded that the resting electrocardiogram
furnishes essential information for the diagnosis, management,
and prognostic evaluation of patients with congestive heart fail-
ure (CHF). Almost any ECG diagnostic entity may turn out to
be useful in the care of patients with CHF, revealing the non-
speciﬁcity of the ECG in CHF. Nevertheless, a number of
CHF/ECG correlates have been proposed and found to be
indispensable in clinical practice; they include, among others,
the ECG diagnoses of myocardial ischemia and infarction, at-
rial ﬁbrillation, left ventricular hypertrophy/dilatation, left
bundle branch block and interventricular conduction delays,
left atrial abnormality, and QT-interval prolongation. In addi-
tion to the above well-known applications of the ECG for pa-
tients with CHF, a recently described association of
peripheral edema (PERED), sometimes even imperceptible by
physical examination, with attenuated ECG potentials, could
extend further the diagnostic range of the clinician. These
ECG voltage attenuations are of extracardiac mechanism,
and impact the amplitude of QRS complexes, P-waves, and
T-waves, occasionally resulting also in shortening of the QRS
complex and QT interval duration. PERED alleviation, in re-
sponse to therapy of CHF, reverses all the above alterations.
These fresh diagnostic insights have potential application in
the follow-up of patients with CHF, and in their selection for
implantation of cardioverter/deﬁbrillator and/or cardiac resyn-
chronization systems. If sought, PERED-induced ECGchanges are abundantly present in the hospital and clinic envi-
ronments; if their detection and monitoring are incorporated in
the clinician’s ‘‘routine’’, considerable improvements in the care
of patients with CHF may be realized.
4.1. Conclusions
 Voltages of electrocardiogram are considered one of
the most important parameters in diagnosis and follow
up of patients with acute or decompensated heart
failure.
 Voltage of chest leads correlates well with left ventricular
end systolic and diastolic dimension.
 Voltage of limb leads has important inverse correlation
with lower limb edema.
 Voltage of electrocardiogram improves with improve-
ment of heart failure and is decreased in case of decom-
pensation. Hence could be used in the follow up of these
cases.
 ECG is a widely available tool that has a prognostic
value in HF. It is an inexpensive tool, simple to perform,
and yields an instant result. We recommend that ECG
should be done not only during hospital course but also
during follow up of patients with acute or decompen-
sated HF.
152 M. Sadaka et al. Considerable improvements in the care of patients with
acute or decompensated heart failure may be realized if
ECG monitoring and follow up are incorporated in clini-
cian’s routine work up.
 Further studies with longer follow up and larger sample
of patients are needed to conﬁrm our results.References
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